943319-70-8

Original
price: Negotiable
minimum:
Total supply:
Delivery term: The date of payment from buyers deliver within days
seat: Beijing
Validity to: Long-term effective
Last update: 2017-12-19 13:14
Browse the number: 176
inquiry
Company Profile
 
 
Product details
If you are going to consult the information about 943319-70-8 from one of the leading 943319-70-8 manufacturers and suppliers in China,Website:://.biopharmaleader.net, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.943319-70-8 Product NamePonatinibSynonymsAP24534FormulaC29H27F3N6OMolecular Weight532.56Spec / Purity98%minSupply CapacityDetailsPonatinib is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph ) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor.Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.
Total0bar [View All]  Related Comments
 
more»Other products

[ Products search ] [ favorites ] [ Tell friends ] [ Print ] [ Close ]